“Explosive Hearing: Philippines’ House of Representatives Investigates 290K+ Excess Deaths Correlated with Experimental Vaccines”
Originally published on Substack
DOH has let us down, has refused to admit that people are dying, turning a blind eye to the people who are getting sick, turbo cancers, myocarditis, children who are suddenly sick as if they are 60-70
An explosive hearing unfolded at the Philippines’ House of Representatives, focusing on the concerning increase of over 290,000 excess deaths. As people start to connect the dots to the roll-out of experimental vaccines, heated discussions ensued, revealing shocking testimonies and data.
Attorney Tanya Lat voiced the frustrations of many Filipinos: “There are Filipino people who are sick and tired of how the DOH has let us down, has refused to admit that people are dying, turning a blind eye to the people who are getting sick, turbo cancers, myocarditis, children who are suddenly sick as if they are 60, 70-year-old people.” Her words resonated in the chamber, painting a grim picture of a Department of Health (DOH) that seems indifferent to the suffering caused by the vaccines. “We look into their eyes, there does not seem to be any sympathy for the people who have died, for the people who are now physically disabled because of these vaccines,” she added.
The tension continued as analyst Sally Clark presented alarming statistics: “This is our birth data. And it shows that we have had a loss of babies every single year since the pandemic has started. So 2019 was our last normal birth year. And the last line at the bottom is 2023.”
As she dissected the data, it became clear that there was a notable and troubling pattern: birth rates are dropping significantly. This data shares similar patterns to those of highly vaccinated countries like Singapore, where they saw a surge in stillbirths and perinatal deaths.
Continue Reading
One of our country’s most important freedoms is that of free speech.
Agree with this essay? Disagree? Join the debate by writing to DailyClout HERE.